Skip to main content
. 2012 Jan 20;15(1):44–48. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2012.01.09

3.

易瑞沙治疗前的治疗情况

Summary of prior therapy

n %
No. of chemotherapy regimens before gefitinib
  0 2 11.1%
  1 11 61.1%
  2 5 27.8%
Best response to gefitinib
  PR 12 66.7%
  SD 6 33.3%
Interval from discontinuation of gefitinib to 2nd EGFR-TKIs
  Median (95%CI) (month) 5.86 (5.42-12.36)
PFS-1stTKI
  Median (95%CI) (month) 12.22 (10.93-18.81)
PFS-2ndTKI
  Median (95%CI) (month) 5.16 (4.44-11.27)